Showing results (131-140 of 149) with videos related to
Sort By:
Pageof 15
Nature Microbiology|April 28, 2022
SARS-CoV-2-specific T-cell epitope repertoire in convalescent and mRNA-vaccinated individualsJulia Lang-Meli, Hendrik Luxenburger, Katharina Wild, et al.Gut|August 4, 2023
Enolase represents a metabolic checkpoint controlling the differential exhaustion programmes of hepatitis virus-specific CD8+ T cellsFrances Winkler, Anna V Hipp, Carlos Ramirez, et al.Immunity|June 26, 2021
Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactionsMarius Schwabenland, Henrike Salié, Jovan Tanevski, et al.Liver Cancer|October 12, 2019
Stereotactic Body Radiation Therapy as an Alternative Treatment for Patients with Hepatocellular Carcinoma Compared to Sorafenib: A Propensity Score AnalysisDominik Bettinger, David J Pinato, Michael Schultheiss, et al.Nature Immunology|December 20, 2024
Efficacy of CTLA-4 checkpoint therapy is dependent on IL-21 signaling to mediate cytotoxic reprogramming of PD-1+CD8+ T cellsZhen Zhang, Marlene Langenbach, Sagar Sagar, et al.Vaccines|November 26, 2024
Impaired SARS-CoV-2-Specific CD8+ T Cells After Infection or Vaccination but Robust Hybrid T Cell Immunity in Patients with Multiple MyelomaKhalid Shoumariyeh, Benedikt Csernalabics, Elahe Salimi Alizei, et al.Journal of Hepatology|November 13, 2024
HBV shows different levels of adaptation to HLA class I-associated selection pressure correlating with markers of replicationTatjana Schwarz, Johannes Ptok, Maximilian Damagnez, et al.Gastroenterology|February 16, 2019
Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8+ T Cells and Evolve at the Population LevelHadi Karimzadeh, Muthamia M Kiraithe, Valerie Oberhardt, et al.Nature|July 28, 2021
Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccineValerie Oberhardt, Hendrik Luxenburger, Janine Kemming, et al.Nature Medicine|November 13, 2020
Characterization of pre-existing and induced SARS-CoV-2-specific CD8+ T cellsIsabel Schulien, Janine Kemming, Valerie Oberhardt, et al.Pageof 15